Status | Study |
Recruiting |
Study Name: Zika Case Definition and Surveillance Study Condition: Zika Virus Disease Date: 2017-05-16 |
Recruiting |
Study Name: Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection. Condition: HIV Infections Zika Virus Infection Date: 2017-05-16 Interventions: Other: Biological sample collection A blood sample collection for the study will be taken to each partic |
Not yet recruiting |
Study Name: Comparison of Heterologous Prime-Boost Vaccination Schedules of Tetravalent Dengue Virus Purified Inactivated Vaccine (PIV) and Tetravalent Dengue Virus Live Attenuated Vaccine (LAV) in Healthy Adults in a Nonendemic Region Condition: Dengue Virus Date: 2017-04-25 Interventions: Biological: TDENV-PIV Dosage: |
Not yet recruiting |
Study Name: Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals Condition: HIV Infections Date: 2017-04-24 Interventions: Biological: Yellow Fever vaccination (17 DD Biomanguinhos) One intramuscular injection |
Not yet recruiting |
Study Name: Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil Condition: Zika Virus Date: 2017-04-03 Interventions: Diagnostic Test: RT-PCR Persistence of detectable Zika virus (by RT-PCR test) in all selected body fluid |
Enrolling by invitation |
Study Name: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents Condition: Zika Virus Zika Virus Infection Virus Diseases Date: 2017-03-28 Interventions: Biological: VRC-ZKADNA090-00-VP |
Recruiting |
Study Name: Yellow Fever Vaccine on Statin/ Non Statin Subjects Condition: Yellow Fever Vaccine Yellow Fever Date: 2017-03-13 Interventions: Drug: Stamaril (live attenuated yellow fever vaccine) They will receive a single dose of 0.5ml of Stamar |
Not yet recruiting |
Study Name: Applying Wolbachia to Eliminate Dengue Condition: Dengue Zika Virus Infection Chikungunya Fever Date: 2017-02-14 Interventions: Biological: Wolbachia-infected Aedes aegypti mosquitoes |
Not yet recruiting |
Study Name: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults Condition: Venezuelan Equine Encephalomyelitis Virus Disease Date: 2017-02-09 Interventions: Biological: VEE Vaccine 0.5 mL of VEE vaccine administered subcutaneously in the upper outer aspect of t |
Active, not recruiting |
Study Name: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans Condition: Crimean-Congo Hemorrhagic Fever Date: 2017-01-11 Interventions: Biological: KIRIM-KONGO-VAX Cr |